Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies

Proteome molecular profiling for discovery and diagnosis

NY

Our technology reveals states, like cancerous or not, or drug responder or not. We do this by detecting many (10s of 1000s) of proteins and their variations and applying advanced analytics.

Get Involved in Proteome molecular profiling for discovery and diagnosis
Claim This Profile →

Company Info

Categories

Precision Medicine/DiagnosticsBiotechAI / MLCancer

Disease Areas

Video

MedStartr Index Score

?
24

What do you think of Proteome molecular profiling for discovery and diagnosis?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Proteome molecular profiling for discovery and diagnosis